Lv31
334 积分 2023-05-23 加入
An updated patent review of anaplastic lymphoma kinase inhibitors (2018–2022)
1小时前
待确认
ALK-positive Large B-cell Lymphoma
1小时前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
14天前
已完结
ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases
17天前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
19天前
已完结
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38− compartment
20天前
已完结
Flow cytometry‐guided ex vivo drug sensitivity testing informs venetoclax‐based therapy in acute undifferentiated leukaemia
21天前
已完结
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study
25天前
已关闭
CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous Leukemia: a modified combination chemotherapeutic combination
26天前
已完结
皖公网安备34019202002308
